12/27/2024
We’ve had a banner year at Fractyl Health. From going public, to presenting compelling data across the country to investors and scientists and receiving a Breakthrough Device designation from the FDA - we're celebrating our successes and looking to a big 2025 full of critical catalysts.
We're deeply appreciative of our employees, our Board, our investors, our physician partners, and most importantly our patients for propelling us forward each day and making significant strides in the fight against and . We look forward to continuing this momentum in 2025!